Open Access
Issue
Med Sci (Paris)
Volume 35, Number 8-9, Août–Septembre 2019
Page(s) 674 - 681
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2019127
Published online 18 September 2019
  1. Dodd S.. Current insights in the placebo and nocebo phenomena. Clin Ther 2017 ; 39 : 456–457. [PubMed] [Google Scholar]
  2. Rief W, Bingel U, Schedlowski M, Enck P. Mechanisms involved in placebo and nocebo responses and implications for drug trials. Clin Pharmacol Ther 2011 ; 90 : 722–726. [CrossRef] [PubMed] [Google Scholar]
  3. Hahn RA. The nocebo phenomenon: concept, evidence, and implications for public health. Prev Med 1997 ; 26 : 607–611. [CrossRef] [PubMed] [Google Scholar]
  4. Wolf S.. Effects of suggestion and conditioning on the action of chemical agents in human subjects: the pharmacology of placebos. J Clin Invest 1950 ; 29 : 100–109. [CrossRef] [PubMed] [Google Scholar]
  5. Autret A. Les effets placebo des relations entre croyances et médecines. Paris: L’Harmattan, 2013: 112 p [Google Scholar]
  6. Lemoine P. Le mystère du placebo. Paris: Odile Jacob, 2006: 238 p [Google Scholar]
  7. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010 Jan 20; (1) : CD003974. [Google Scholar]
  8. Colagiuri B, Schenk LA, Kessler MD, et al. The placebo effect: from concepts to genes. Neuroscience 2015 ; 307 : 171–190. [Google Scholar]
  9. Wartolowska KA, Feakins BG, Collins GS, et al. The magnitude and temporal changes of response in the placebo arm of surgical randomized controlled trials: a systematic review and meta-analysis. Trials 2016 ; 17 : 589. [Google Scholar]
  10. Cragg JJ, Warner FM, Finnerup NB, et al. Meta-analysis of placebo responses in central neuropathic pain: impact of subject, study, and pain characteristics. Pain 2016 ; 157 : 530–540. [CrossRef] [PubMed] [Google Scholar]
  11. Thomas KB. General practice consultations: is there any point in being positive?. Br Med J Clin Res Ed 1987 ; 294 : 1200–1202. [CrossRef] [PubMed] [Google Scholar]
  12. Turner JA. The importance of placebo effects in pain treatment and research. JAMA 1994 ; 271 : 1609. [CrossRef] [PubMed] [Google Scholar]
  13. Meissner K, Fässler M, Rücker G, et al. Differential effectiveness of placebo treatments: A systematic review of migraine prophylaxis. JAMA Intern Med 2013 ; 173 : 1941. [CrossRef] [PubMed] [Google Scholar]
  14. Kaptchuk TJ. Placebo studies and ritual theory: a comparative analysis of Navajo, acupuncture and biomedical healing. Philos Trans R Soc Lond B Biol Sci 2011 ; 366 : 1849–1858. [CrossRef] [PubMed] [Google Scholar]
  15. Kerr CE, Shaw JR, Conboy LA, et al. Placebo acupuncture as a form of ritual touch healing: a neurophenomenological model. Conscious Cogn 2011 ; 20 : 784–791. [CrossRef] [PubMed] [Google Scholar]
  16. Geuter S, Koban L, Wager TD. The cognitive neuroscience of placebo effects: Concepts, predictions, and physiology. Annu Rev Neurosci 2017 ; 40 : 167–188. [CrossRef] [PubMed] [Google Scholar]
  17. Wager TD. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004 ; 303 : 1162–1167. [Google Scholar]
  18. Schafer SM, Colloca L, Wager TD. Conditioned placebo analgesia persists when subjects know they are receiving a placebo. J Pain 2015 ; 16 : 412–420. [Google Scholar]
  19. de la Fuente-Fernandez R.. Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science 2001 ; 293 : 1164–1166. [Google Scholar]
  20. Hall KT, Lembo AJ, Kirsch I, et al. Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One 2012 ; 7 : e48135. [CrossRef] [PubMed] [Google Scholar]
  21. Tacheau M, Reny J, Crépin E, et al. Le placebo a-t-il sa place dans la relation soignant-soigné à l’hôpital ?. Éthique et Santé 2017 ; 14 : 4–10. [Google Scholar]
  22. Hawke K, van Driel ML, Buffington BJ, et al. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children. Cochrane Database Syst Rev 2018; 9 : CD005974. [PubMed] [Google Scholar]
  23. Sherman R, Hickner J. Academic physicians use placebos in clinical practice and believe in the mind–body connection. J Gen Intern Med 2008 ; 23 : 7–10. [Google Scholar]
  24. Berthelot JM, Maugars Y, Abgrall M, Prost A. Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. Jt Bone Spine Rev Rhum 2001 ; 68 : 65–70. [CrossRef] [Google Scholar]
  25. Fässler M, Meissner K, Schneider A, Linde K. Frequency and circumstances of placebo use in clinical practice: a systematic review of empirical studies. BMC Med 2010 ; 8 : 15. [CrossRef] [PubMed] [Google Scholar]
  26. Haour F.. Mécanismes de l’effet placebo et du conditionnement : Données neurobiologiques chez l’homme et l’animal. Med Sci (Paris) 2005 ; 21 : 315–319. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  27. Bouhassira D. L’anti-douleur. Paris: Le Cherche-Midi, 2018: 208 p [Google Scholar]
  28. Guess HA. The science of the placebo: toward an interdisciplinary research agenda. Londres: BMJ Books, 2002: 332 p [Google Scholar]
  29. Kong J, Spaeth R, Cook A, et al. Are all placebo effects equal? Placebo pills, sham acupuncture, cue conditioning and their association. PLoS One 2013 ; 8 : e67485. [CrossRef] [PubMed] [Google Scholar]
  30. Finniss DG, Benedetti F. Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain 2005 ; 114 : 3–6. [CrossRef] [PubMed] [Google Scholar]
  31. Vital Durand D, Fassier T. Peut-on étudier scientifiquement le placebo ? Médecine Thérapeutique 2010; 16 : 252–8. [Google Scholar]
  32. de Craen AJ, Tijssen JG, de Gans J, Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 2000 ; 247 : 183–188. [CrossRef] [PubMed] [Google Scholar]
  33. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects?. J Clin Epidemiol 2000 ; 53 : 786–792. [CrossRef] [PubMed] [Google Scholar]
  34. Schaefer M, Sahin T, Berstecher B. Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis. PLoS One 2018 ; 13 : e0192758. [CrossRef] [PubMed] [Google Scholar]
  35. Locher C, Frey Nascimento A, Kirsch I, et al. Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia. Pain 2017 ; 158 : 2320–2328. [CrossRef] [PubMed] [Google Scholar]
  36. Kaptchuk TJ, Friedlander E, Kelley JM, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One 2010 ; 5 : e15591. [CrossRef] [PubMed] [Google Scholar]
  37. Carvalho C, Caetano JM, Cunha L, et al. Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain 2016 ; 157 : 2766–2772. [CrossRef] [PubMed] [Google Scholar]
  38. Jordan B.. Cancer : thérapies « complémentaires » et observance du traitement anti-tumoral font-elles bon ménage ?. Med Sci (Paris) 2018 ; 34 : 999–1002. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.